Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
The American Journal of Managed Care|October 18, 2011
Pharmacist-provided telephonic medication therapy management in an MAPD planMelea A Ward, Yihua XuAmerican Health & Drug Benefits|May 13, 2015
Is response-guided therapy being applied in the clinical setting? The hepatitis C exampleJennifer B Harris, Melea A Ward, Phil SchwabAmerican Health & Drug Benefits|September 20, 2014
Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: where do we go from here?Mary S Hayes, Melea A Ward, S Lane Slabaugh, et al.Cancer Investigation|April 8, 2021
Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based AnalysisVictoria T Brown, Dana Drzayich Antol, Patrick N Racsa, et al.Current Medical Research and Opinion|November 25, 2014
Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costsMelea A Ward, Gang Fang, Kristy L Richards, et al.Journal of Health Economics and Outcomes Research|September 4, 2023
Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid LeukemiaMelea A Ward, Gang Fang, Kristy L Richards, et al.Journal of Evaluation in Clinical Practice|September 15, 2011
Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health planYihua Xu, Hema N Viswanathan, Melea A Ward, et al.Pageof 1